r-hFSH
Sponsors
Merck KGaA, Darmstadt, Germany, Reproductive Medicine Associates of New Jersey, Finox AG
Conditions
InfertilityOutcome During r-hFSH StimulationOutcome During r-hFSH and r-hLH StimulationOvulation InductionReproductive Techniques, Assisted
Phase 2
A Phase II Study to Assess the Efficacy and Safety of Luveris® (Lutropin Alfa) in Mid Follicular Phase for Controlled Ovarian Stimulation (COS) in Advanced Reproductive Age
TerminatedNCT01079949
Start: 2007-11-30End: 2010-10-31Updated: 2014-02-27
A Study to Evaluate Safety and Efficacy of Recombinant Human Luteinizing Hormone (r-hLH) Compared With Urinary Human Chorionic Gonadotrophin (u-hCG) to Trigger Ovulation in Infertile Women
CompletedNCT01735422
Start: 1999-12-31End: 2001-07-31Updated: 2014-02-04
Phase 3
Unknown Phase
Use of r-hLH (Luveris) in Donors Previously Treated With r-hFSH (Gonal F)
CompletedNCT01223079
Start: 2005-12-31End: 2008-12-31Updated: 2013-03-05
Observational Post-Authorisation Study on the Use of Bemfola® in Human Assisted Reproductive Techniques in Spain.
CompletedNCT02941341
Start: 2016-10-31End: 2019-04-30Updated: 2020-02-05
Post-Authorisation Study on the Use of Bemfola® in Human Assisted Reproductive Technology
CompletedNCT02942849
Start: 2016-09-30End: 2018-12-31Updated: 2020-02-05